Long-term Outcomes in Treatment of Invasive Bladder Cancer With Concomitant Boost and Accelerated Hyperfractionated Radiation Therapy

CANYILMAZ E., Yavuz M. N., Serdar L., HANEDAN USLU G. D., Zengin A. Y., AYNACI Ö., ...More

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol.90, no.3, pp.562-569, 2014 (SCI-Expanded) identifier identifier identifier


Purpose: The aim of this study was to evaluate the long-term clinical efficacy and toxicity of concomitant boost and accelerated hyperfractionated radiation therapy (CBAHRT) in patients with invasive bladder cancer.